OR
Oruka Therapeutics, Inc. (ORKA)
NASDAQ·Healthcare·Biotechnology
$72.70
-4.83%
Mkt Cap $2.58B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | — | — | — | -$0.61 | -$0.45 | +26.23% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.56 | -$0.55 | +1.79% | — | — |
| Q3 2025 Aug 11, 2025 | — | — | — | -$0.48 | -$0.46 | +4.17% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$0.57 | -$0.40 | +29.82% | — | — |
| Q1 2025 Mar 6, 2025 | — | — | — | -$0.68 | -$0.49 | +27.94% | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$0.40 | -$1.46 | -265.00% | — | — |
| Q3 2024 Aug 27, 2024 | — | — | — | — | -$1.53 | — | — | — |
| Q2 2024 Apr 25, 2024 | — | — | — | — | -$0.14 | — | — | — |
| Q4 2023 Dec 31, 2023 | — | — | — | — | -$0.08 | — | — | — |
| Q3 2023 Sep 30, 2023 | — | — | — | — | -$0.10 | — | — | — |
| Q2 2023 Jun 30, 2023 | — | — | — | — | -$0.10 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | -$0.09 | — | — | — |
| Q4 2022 Dec 31, 2022 | — | — | — | — | -$0.98 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | — | — | — | -$1.94 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | — | — | — | -$2.62 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$2.72 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | -$26.88 | -$4.73 | +82.42% | — | — |
| Q3 2021 Sep 30, 2021 | — | — | — | -$27.60 | -$3.92 | +85.78% | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | -$28.44 | -$4.03 | +85.85% | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | -$22.44 | -$3.98 | +82.26% | — | — |